The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Search articles by EPIC code

This Insulin Pioneer with Market Share is Worth a Look as Diabetes Cases Rise

2020-11-03 08:10:00

Hello, Share Gatherers. I’ve covered Novo-Nordisk (0QIU) before but it now seems to me even more likely to be a reasonable addition to our portfolios. We all know that diabetes is terribly common. Many of your friends and relatives will have the condition. Novo Nordisk makes half the world’s insulin. So you can see the scale of demand for Novo products. And sadly it’s only likely to grow...


New Diabetes Treatment Hopes Make this Danish Giant Worth a Look

2020-10-13 08:15:37

Hello, Share Gatherers. Novo Nordisk (0QIU) is one of those rare companies to show an increase in sales over the last half-year. Underlying sales improved by 7%. The reason is that it’s a giant medical pioneer and most similar companies are popular at the moment...


Anyone Fancy a Danish? This Nordic Medical Jumbo Should Prosper as Diabetes Cases Grow

2020-07-23 08:20:46

Hello, Share Munchers. It was never going to be long before this old fan of pharmaceutical outfits returned with another medical recommendation for you to look into. My choice today is Novo-Nordisk (0QIU), some of its shares being listed in London. As you might expect the virus has had little impact on this Danish company which focuses on the treatment of diabetes.

Search ShareProphets |

Recent Comments |

About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip


Terms of Service

Privacy Policy

Cookie Policy

Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen